OREXO AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.15 SEK | +3.17% |
|
+9.81% | +36.80% |
| May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
| Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
Chart calendar Orexo AB
d8760ddcbc8c0ac4c144cb70fcf.GrDHpA6rmPqHL5DQdzpA97eeYFgOhimXUhpA1ILTGcE.VvHy8mXl_aXYHtqzJlIHpfXbBRZ7zx_ECnlzvM2EQKVL1bX9ap7tk9BDxQ~559dd40e4c9c1fb075675c4482c80cad
Upcoming events on Orexo AB
Past events on Orexo AB
| 2024-05-08 07:00 am | Q1 2024 Earnings Call |
| 2024-05-08 02:00 am | Q1 2024 Earnings Release |
| 2024-04-26 10:00 am | Annual General Meeting |
| 2024-03-04 | Carnegie Healthcare Conference |
| 2024-02-08 08:00 am | Q4 2023 Earnings Call |
| 2024-02-08 02:23 am | Q4 2023 Earnings Release |
| 2023-11-02 09:00 am | Q3 2023 Earnings Call |
| 2023-11-02 03:22 am | Q3 2023 Earnings Release |
| 2023-10-26 09:00 am | Extraordinary Shareholders Meeting |
| 2023-09-13 | Pareto Securities' Healthcare Conference |
| 2023-07-18 09:00 am | Q2 2023 Earnings Call |
| 2023-07-18 02:00 am | Q2 2023 Earnings Release |
| 2023-06-22 09:30 am | OTC Life Science Investor Forum |
| 2023-05-30 | ABG Sundal Collier Life Science Summit |
| 2023-04-27 08:00 am | Q1 2023 Earnings Call |
| 2023-04-27 02:33 am | Q1 2023 Earnings Release |
| 2023-04-18 10:00 am | Annual General Meeting |
| 2023-03-07 | Stockholm Corporate Finance Life Science Days |
| 2023-01-26 08:00 am | FY 2022 Earnings Call |
| 2023-01-26 02:25 am | FY 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 845 849 -0.44% | 664 660 0.53% | 565 566 -0.23% | 624 628 -0.52% | 639 627 1.89% | 611 |
|
EBITDA Million SEK | Released Forecast Spread | 272 278 -2.11% | 19,0 -70,5 126.93% | -161 -151 -6.53% | -115 -74,3 -55.1% | -32,5 -59,3 45.21% | 52,3 |
|
EBIT Million SEK | Released Forecast Spread | 231 253 -8.45% | -19,9 -98,8 79.86% | -214 -190 -12.68% | -184 -182 -0.98% | -110 -121 9.63% | -30,1 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 228 278 -17.96% | -38,3 -90,2 57.52% | -223 -197 -13.19% | -170 -160 -6.82% | -140 -146 4.15% | -72,0 |
|
Net income Million SEK | Released Forecast Spread | 219 270 -18.94% | -84,4 -118 28.58% | -224 -197 -13.5% | -178 -170 -4.34% | -128 -122 -5.17% | -67,0 |
|
EPS SEK | Released Forecast Spread | 6,20 7,79 -20.4% | -2,45 -3,34 26.72% | -6,51 -5,73 -13.61% | -5,17 -4,93 -4.87% | -3,73 -3,55 -5.07% | -1,95 |
| Announcement Date | 30/01/20 | 28/01/21 | 27/01/22 | 26/01/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 156 161 -3.04% | 159 153 4.13% | 158 154 2.54% | 156 154 1.17% | 166 161 2.85% | 139 144 -3.53% | 159 | 158 | 155 | |
|
EBITDA Million SEK | Released Forecast Spread | -53,1 -51,6 -2.91% | -41,1 -54,5 24.59% | 5,60 -26,0 121.54% | -9,50 -4,60 -106.52% | 12,4 15,5 -20% | 15,9 6,30 152.38% | 18,4 | 9,10 | 8,90 | |
|
EBIT Million SEK | Released Forecast Spread | -71,1 -67,4 -5.49% | -59,3 -72,4 18.09% | -12,9 -44,2 70.81% | -28,6 -23,1 -23.81% | -8,60 -3,00 -186.67% | -4,70 -14,9 68.46% | -2,20 | -11,5 | -11,7 | |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -95,5 -73,9 -29.23% | -68,5 -80,2 14.59% | -15,8 -53,7 70.58% | -36,6 -32,3 -13.31% | -19,5 -12,0 -62.5% | -9,80 -27,4 64.23% | -14,7 | -24,0 | -23,2 | |
|
Net income Million SEK | Released Forecast Spread | -26,5 | -91,8 -73,9 -24.22% | -63,9 -80,2 20.32% | -12,6 -53,7 76.54% | -33,3 -25,8 -29.07% | -18,6 -9,60 -93.75% | -8,90 -26,6 66.54% | -13,8 | -22,5 | -21,8 |
|
EPS SEK | Released Forecast Spread | -0,77 | -2,67 -2,15 -24.19% | -1,86 -2,33 20.17% | -0,37 -0,92 59.78% | -0,97 -0,92 -5.43% | -0,54 -0,92 41.3% | -0,26 -0,77 66.23% | -0,40 | -0,65 | -0,63 |
| Announcement Date | 03/11/22 | 26/01/23 | 27/04/23 | 18/07/23 | 02/11/23 | 08/02/24 | 08/05/24 | - | - | - |
More events
Past sector events for Orexo AB
| 2024-05-15 01:00 am | MERCK KGAA: Q1 2024 Earnings Release |
| 2024-05-12 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 | OSCOTEC INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-08 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-06 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
| 2024-04-29 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-29 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
| 2024-04-29 | YUHAN CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ORX Stock
- Calendar Orexo AB
